{"DataElement":{"publicId":"3162577","version":"1","preferredName":"Person Saccharomyces Cerevisiae Hypersensitivity Skin Testing Result","preferredDefinition":"Text term for the hypersensitivity/allergic response to Baker's Yeast (S. cerevisiae) skin testing.","longName":"PER_BAKYST_TST_RSL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3162566","version":"1","preferredName":"Person Saccharomyces Cerevisiae Hypersensitivity Skin Testing Result","preferredDefinition":"A person's experience of a hypersensitivity/allergic response to the adminstration of an agent; a reaction can range from mild dermatologic or hypertensive signs to acute anaphylaxis._A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" yeast. The dried form is used as a dietary supplement._A local or general reaction of an organism following contact with a specific allergen to which it has been previously exposed and to which it has become sensitized._A preparation of an antigenic component of an infectious agent that is administered to a patient in order to determine whether previous exposure to the agent has occurred, and/or to assess the integrity of the patient's cellular immune system.  Depending on the clinical situation, the appearance of a delayed (cellular) hypersensitivity response, which manifests as an area of induration and erythema at the injection site, i.e. a positive test result, may indicate previous exposure to a particular infectious agent. (NCI04)_A preparation of an antigenic component of an infectious agent that is administered to a patient in order to determine whether previous exposure to the agent has occurred, and/or to assess the integrity of the patient's cellular immune system.  Depending on the clinical situation, the appearance of a delayed (cellular) hypersensitivity response, which manifests as an area of induration and erythema at the injection site, i.e. a positive test result, may indicate previous exposure to a particular infectious agent. (NCI04)_Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"PER_BAKYST_TST_RSL","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3162564","version":"1","preferredName":"Person Saccharomyces cerevisiae Skin Test","preferredDefinition":"Person; a human being.:A species of unicellular fungus used as a research subject and in baking and beer brewing.:A preparation of an antigenic component of an infectious agent that is administered to a patient in order to determine whether previous exposure to the agent has occurred, and/or to assess the integrity of the patient's cellular immune system.  Depending on the clinical situation, the appearance of a delayed (cellular) hypersensitivity response, which manifests as an area of induration and erythema at the injection site, i.e. a positive test result, may indicate previous exposure to a particular infectious agent. (NCI04)","longName":"C25190:C14271:C17137","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Saccharomyces cerevisiae","conceptCode":"C14271","definition":"A species of unicellular fungus used as a research subject and in baking and beer brewing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Skin Test","conceptCode":"C17137","definition":"A preparation of an antigenic component of an infectious agent that is administered to a patient in order to determine whether previous exposure to the agent has occurred, and/or to assess the integrity of the patient's cellular immune system.  Depending on the clinical situation, the appearance of a delayed (cellular) hypersensitivity response, which manifests as an area of induration and erythema at the injection site, i.e. a positive test result, may indicate previous exposure to a particular infectious agent. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B4CCBE-5C58-4C3E-E040-BB89AD4315C8","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177339","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"Result","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528F-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B4CCBE-5C66-4C3E-E040-BB89AD4315C8","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3162569","version":"1","preferredName":"Delayed-Type Hypersensitivity Result","preferredDefinition":"Delayed hypersensitivity reaction (DTH) - type IV reaction, an inflammatory response that develops 24 to 72 hours after exposure to an antigen that the immune system recognizes as foreign. DTH is mediated by T cells rather than by antibodies. Th1 cells produce interferon gamma, interleukin (IL)-2, and tumor necrosis factor-beta and promote a cell-mediated immune response._Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"DTH_RSL","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"3162570","version":"1","preferredName":"Positive Finding","longName":"3162570","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B4CCBE-5C9F-4C3E-E040-BB89AD4315C8","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"TSESU","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95B4CCBE-5CB8-4C3E-E040-BB89AD4315C8","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"3162571","version":"1","preferredName":"Negative Finding","longName":"3162571","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B4CCBE-5CC2-4C3E-E040-BB89AD4315C8","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95B4CCBE-5CDB-4C3E-E040-BB89AD4315C8","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3162568","version":"1","preferredName":"Delayed-Type Hypersensitivity Outcome","preferredDefinition":"Delayed hypersensitivity reaction (DTH) - type IV reaction, an inflammatory response that develops 24 to 72 hours after exposure to an antigen that the immune system recognizes as foreign. DTH is mediated by T cells rather than by antibodies. Th1 cells produce interferon gamma, interleukin (IL)-2, and tumor necrosis factor-beta and promote a cell-mediated immune response.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C3115:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type IV Hypersensitivity","conceptCode":"C3115","definition":"Delayed hypersensitivity reaction (DTH) - type IV reaction, an inflammatory response that develops 24 to 72 hours after exposure to an antigen that the immune system recognizes as foreign. DTH is mediated by T cells rather than by antibodies. Th1 cells produce interferon gamma, interleukin (IL)-2, and tumor necrosis factor-beta and promote a cell-mediated immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B4CCBE-5C7B-4C3E-E040-BB89AD4315C8","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B4CCBE-5C8C-4C3E-E040-BB89AD4315C8","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"},{"publicId":"2812605","version":"1","longName":"Lombardi New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Result","type":"Preferred Question Text","description":"Result","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B4CCBE-5CE5-4C3E-E040-BB89AD4315C8","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}